Chronically immunocompromised patients have a markedly increased risk of developing lymphoproliferative ... Kaposi's sarcoma (KS), Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).

Lymphoproliferative disorders can be pretty serious, as they mean your immune system doesn't work the way it should. They can ...

Calquence is under clinical development by AstraZeneca and currently in Phase II for Splenic Marginal Zone B-Cell Lymphoma.

Distinction between atypical lymphoid proliferations with follicular pattern and follicular lymphoma. Atypical lymphoid proliferations with follicular pattern Follicular lymphoma Table 4.

EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a ...

CMC-544 has high efficacy in combination with rituximab for follicular lymphoma (FL) and diffuse large B-cell lymphoma, at the expense of moderate toxicity. BL22 and HA22 have high durable ...